Podcast
Podcaster
Beschreibung
vor 1 Monat
Biotech investor BB Biotech delivered a strong performance in
2025, benefiting significantly from a resurgence of investor
interest in the sector. In this podcast, Christian Koch, Head of
the BB Biotech Team, discusses why the fundamentals in the
biotech market are improving, why acquisitions are once again
becoming a key value driver—and what clinical breakthroughs and
investment opportunities he expects to see in the coming years.
Weitere Episoden
12 Minuten
vor 3 Tagen
13 Minuten
vor 1 Woche
11 Minuten
vor 2 Wochen
14 Minuten
vor 2 Wochen
23 Minuten
vor 3 Wochen
Kommentare (0)
Melde Dich an, um einen Kommentar zu schreiben.